Carcinoma, Non-Small-Cell Lung
Anaplastic Large Cell Lymphoma
Diffuse Large Cell Lymphoma
Inflammatory Myofibroblastic Tumors
Go to clinicaltrialsDOTgov, AND seach AP26113.
You will see the trials.
Sentiment: Strong Buy
I bought today too. No reason for another sell off form $4.00 to here. Inclusing development had been then stopped and hence the drop to $4.00, but another shoe drop is, I believe, OVERDONE. I see back to $4.00.
And ARIA has CASH $1.90 PER SHARE.
It is trading at $ .90 per share now.
Even if all 6 (seven) phase 2 drugs with Inclusing disappears in development, it is still extremely cheap.
funds needed to double up... hence the drop to $2.. the pump back to $4 +100%.. this guys aint stupid..